Finzati - Logo
ICUI logo

ICU Medical, Inc.

ICUI • Medical - Instruments & Supplies
$161.08
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.03B
Growth
14.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 9.9%Positive free cash flow · 3.73Consistent free cash flow · 4/5Manageable debt level · 0.66Healthy liquidity · 2.36
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:51 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$161.08
Change0.00%
Shares Out25.04M
Market Cap$4.03B
Enterprise Value$4.97B
52W Range107.00 - 176.27
Beta0.76
P/E134.07
P/S1.87
P/B1.87
P/FCF22.58
EV/Sales2.30

Investment DNA

How strong this company looks for long-term investors

57
out of 100
Business Quality
Margins, moat, returns
35/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
57/100
Price Attractiveness
Cheap or expensive today
61/100
Why this score▼
Positive revenue growth · 9.9%Positive free cash flow · 3.73Consistent free cash flow · 4/5Manageable debt level · 0.66Healthy liquidity · 2.36Expensive earnings multiple · 4802.44

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$163.00
Mean
$182.00
Median
$182.00
High
$200.00

Company Overview

IPO: 3/31/1992
Industry: Medical - Instruments & Supplies
P/B i: 1.87
Debt / Equity i: 0.66
Operating Margin: 4.80%
Net Margin: 0.03%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.66
Current Ratio: 2.36
Quick Ratio: 1.13
Status: Good

Insider Transactions

Recent executive and insider activity

Woolson Daniel
Transaction: 05/22/2026
SELL
Change
-2,123
Price
$132.21
Filing
05/22/2026
Type
SELL
Sanzone Virginia Ruth
Transaction: 05/14/2026
SELL
Change
-2,447
Price
$124.08
Filing
05/15/2026
Type
SELL
Greenberg David C.
Transaction: 05/13/2026
SELL
Change
-1,254
Price
Not reported
Filing
05/13/2026
Type
SELL